These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20233880)

  • 1. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance.
    Chin AI; Miyahira AK; Covarrubias A; Teague J; Guo B; Dempsey PW; Cheng G
    Cancer Res; 2010 Apr; 70(7):2595-603. PubMed ID: 20233880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
    Peek EM; Song W; Zhang H; Huang J; Chin AI
    Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breaking immune tolerance by targeting CD25+ regulatory T cells is essential for the anti-tumor effect of the CTLA-4 blockade in an HLA-DR transgenic mouse model of prostate cancer.
    Klyushnenkova EN; Riabov VB; Kouiavskaia DV; Wietsma A; Zhan M; Alexander RB
    Prostate; 2014 Oct; 74(14):1423-32. PubMed ID: 25111463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells.
    Akazawa T; Ebihara T; Okuno M; Okuda Y; Shingai M; Tsujimura K; Takahashi T; Ikawa M; Okabe M; Inoue N; Okamoto-Tanaka M; Ishizaki H; Miyoshi J; Matsumoto M; Seya T
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):252-7. PubMed ID: 17190817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PolyI:C plus IL-2 or IL-12 induce IFN-gamma production by human NK cells via autocrine IFN-beta.
    Duluc D; Tan F; Scotet M; Blanchard S; Frémaux I; Garo E; Horvat B; Eid P; Delneste Y; Jeannin P
    Eur J Immunol; 2009 Oct; 39(10):2877-84. PubMed ID: 19728309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo.
    Takemura R; Takaki H; Okada S; Shime H; Akazawa T; Oshiumi H; Matsumoto M; Teshima T; Seya T
    Cancer Immunol Res; 2015 Aug; 3(8):902-14. PubMed ID: 25898986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-β.
    Costello DA; Lynch MA
    Hippocampus; 2013 Aug; 23(8):696-707. PubMed ID: 23554175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism.
    Paone A; Starace D; Galli R; Padula F; De Cesaris P; Filippini A; Ziparo E; Riccioli A
    Carcinogenesis; 2008 Jul; 29(7):1334-42. PubMed ID: 18566014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
    Degl'Innocenti E; Grioni M; Capuano G; Jachetti E; Freschi M; Bertilaccio MT; Hess-Michelini R; Doglioni C; Bellone M
    Cancer Res; 2008 Jan; 68(1):292-300. PubMed ID: 18172322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 3-initiated antiviral responses in mouse male germ cells in vitro.
    Wang T; Zhang X; Chen Q; Deng T; Zhang Y; Li N; Shang T; Chen Y; Han D
    Biol Reprod; 2012 Apr; 86(4):106. PubMed ID: 22262694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells.
    Han JH; Park SY; Kim JB; Cho SD; Kim B; Kim BY; Kang MJ; Kim DJ; Park JH; Park JH
    Am J Reprod Immunol; 2013 Oct; 70(4):317-26. PubMed ID: 23790156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance.
    Thornley TB; Phillips NE; Beaudette-Zlatanova BC; Markees TG; Bahl K; Brehm MA; Shultz LD; Kurt-Jones EA; Mordes JP; Welsh RM; Rossini AA; Greiner DL
    J Immunol; 2007 Nov; 179(10):6620-9. PubMed ID: 17982052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
    Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
    Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of ISCOMATRIX adjuvant and TLR agonists induces regression of established solid tumors in vivo.
    Silva A; Mount A; Krstevska K; Pejoski D; Hardy MP; Owczarek C; Scotney P; Maraskovsky E; Baz Morelli A
    J Immunol; 2015 Mar; 194(5):2199-207. PubMed ID: 25646304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporally designed treatment of melanoma cells by ATRA and polyI: C results in enhanced chemokine and IFNβ secretion controlled differently by TLR3 and MDA5.
    Szabo A; Osman RM; Bacskai I; Kumar BV; Agod Z; Lanyi A; Gogolak P; Rajnavolgyi E
    Melanoma Res; 2012 Oct; 22(5):351-61. PubMed ID: 22797253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
    Jiang Q; Wei H; Tian Z
    BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
    Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
    Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
    Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
    J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontline Science: TLR3 activation inhibits food allergy in mice by inducing IFN-γ
    Hong JY; Li SS; Hu TY; Liu ZQ; Yu D; Yu HQ; Guan L; Wu GH; Zeng HT; Liu ZG; Yang PC
    J Leukoc Biol; 2019 Dec; 106(6):1201-1209. PubMed ID: 30997942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta2 integrin CD11b attenuates polyinosinic:polycytidylic acid-induced hepatitis by negatively regulating natural killer cell functions.
    Zhang M; Han Y; Han C; Xu S; Bao Y; Chen Z; Gu Y; Xia D; Cao X
    Hepatology; 2009 Nov; 50(5):1606-16. PubMed ID: 19821527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.